US Firms Warned On Linking Vaping With Wellness
Executive Summary
Warnings to five marketers don’t state smoking cessation claims and vaping also aren’t related. Rather providing nicotine replacement therapy, the products identified in the warnings were reported as being marketed with claims including “Fight off tumors and alleviate symptoms of chemotherapy."
You may also be interested in...
Will Novel NRT Interest Heat Up In US With First Clearance For ENDS Under Tobacco Control Act?
Without mentioning NRT space, FDA’s acceptance of one vape device and two replacement nicotine cartridges as tobacco products might reignite interest in proposals for ENDS or other novel products to be approved for smoking cessation claims. To gain clearance as tobacco products, the ENDS were shown to provide a benefit similar to efficacies required for an NRT.
GSK’s Proposal For Mouth Spray Nicorette Delayed By FDA Questions On Label
Glaxo plans to make changes FDA requested in Complete Response letter sent on 18 October, the agency’s deadline for acting on NDA for an oral spray that delivers 1 mg per spray of aqueous buffered nicotine solution for oromucosal use.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.